An updated general approach for achieving BP goals in people with diabetes. An updated general approach for achieving BP goals in people with diabetes.

Slides:

Advertisements

Similar presentations

Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema Effect of renin-angiotensin system blockade on calcium.

Advertisements

JNC 8 Guidelines….

The British Approach to Antihypertensive Therapy: Guidelines from the National Institute of Health and Clinical Excellence Power Over Pressure

Hypertension Diagnosis and Treatment  Based on JNC 7 – published in 2003  Goal: BP

Efficacy and safety of angiotensin receptor blockers: a meta-analysis of randomized trials Elgendy IY et al. Am J Hypertens. 2014; doi:10,1093/ajh/hpu209.

Selection of Antihypertensive Drug. BP ClassificationSystolic BP, mm Hg Diastolic BP, mm Hg Normal

Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.

New Guidelines for Myocardial Ischemia Management.

JNC 7 血壓分期. 血壓分期 JNC 7 ： 1. 增加高血壓前期 2.Stages 2 及 3 高血壓被合併 JNC 7, 2003.

Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Renoprotective Effect of Renin-Angiotensin-Aldosterone.

Hypertension In The Stroke Patient

Hypertension JNC VIII Guidelines.

Copyright © 2015 American Medical Association. All rights reserved.

Hypertension treatment guidelines from the United Kingdom’s National Institute for Health and Care Excellence. Guidelines identify angiotensin-converting.

Effect of Renin-Angiotensin System Blockade on Calcium Channel Blocker-Associated Peripheral Edema Harikrishna Makani, MD, Sripal Bangalore, MD, MHA,

Algorithm for guideline-directed medical therapy for patients with SIHD. Colors correspond to the class of recommendations in the ACCF/AHATable The.

Subclinical organ damage Treatment LVH

Isolated Systolic Hypertension: An Update After SPRINT

Current and future paradigm for prognostication and testing of therapeutics in patients with heart failure using machine learning. Current and future paradigm.

Hypertension: A Risk Factor For Stroke

Results of random-effects meta-analysis of association between use of angiotensin-converting-enzyme (ACE) inhibitors or angiotensin-receptor blockers and.

WHI Observational Study: Cardiovascular death in women with hypertension but no history of CVD on monotherapy CVD death Diuretic, HR (95% CI) ACE inhibitor,

Mean BP from initial visit to four years

Induction of Type 2 Diabetes Mellitus with Antihypertensive Therapy: Is There Any Role of Alpha Adducin, ACE, and IRS-1 Gene? Sumeet Gupta, MPharm, PhD,

Viper venom for diabetic nephropathy

Nat. Rev. Nephrol. doi: /nrneph

Frederic Rahbari-Oskoui, MD, MS American Journal of Kidney Diseases

Thinking Beyond New Clinical Guidelines: Update in Hypertension

Drug Rate ratio 95% CI Thiazide diuretics 1.0 Reference ACE inhibitors

Step Care Therapy for Hypertension in Diabetic Patients

Outcomes with Angiotensin-converting Enzyme Inhibitors vs Other Antihypertensive Agents in Hypertensive Blacks Sripal Bangalore, MD, MHA, Gbenga Ogedegbe,

Deborah J. Clegg, PhD, Michael Cody, MD, Biff F. Palmer, MD

Recommendations for the treatment of confirmed hypertension in people with diabetes. *An ACE inhibitor (ACEi) or ARB is suggested to treat hypertension.

Membranous nephropathy: When and how to treat

Viper venom for diabetic nephropathy

Recognition, Pathogenesis, and Treatment of Different Stages of Nephropathy in Patients With Type 2 Diabetes Mellitus George L. Bakris, MD Mayo Clinic.

Volume 81, Issue 7, Pages (April 2012)

Nat. Rev. Cardiol. doi: /nrcardio

Audit-based education: a potentially effective program for improving guideline achievement in CKD patients Moniek C.M. de Goeij, Joris I. Rotmans Kidney.

Table of Contents Why Do We Treat Hypertension? Recommendation 5

Resistant Hypertension and the Pivotal Role for Mineralocorticoid Receptor Antagonists: A Clinical Update 2016 Murray Epstein, MD, Daniel A. Duprez,

Volume 94, Issue 3, Pages (September 2018)

Measure-specific reasons for exclusion (2010-Q4–2013-Q3).

Volume 72, Issue 12, Pages (December 2007)

Cardiac medications and their association with cardiovascular events in incident dialysis patients: Cause or effect? Areef Ishani, Charles A. Herzog,

Treatment Algorithm for Guideline-Directed Medical Therapy Including Novel Therapies (2,9) Green diamonds indicate Class I guideline recommendations, while.

by Ali Albasri, Suman Prinjha, Richard J McManus, and James P Sheppard

Rami Doukky et al. JCHF 2016;4:24-35

Effect of Renin-Angiotensin System Blockade on Calcium Channel Blocker-Associated Peripheral Edema Harikrishna Makani, MD, Sripal Bangalore, MD, MHA,

by Ali Albasri, Suman Prinjha, Richard J McManus, and James P Sheppard

The future of renoprotection: Frustration and promises

Managing Blood Pressure

Volume 84, Issue 5, Pages (November 2013)

Isolated Systolic Hypertension: An Update After SPRINT

Comparative Superiority of ACE Inhibitors Over Angiotensin Receptor Blockers for People With CKD: Does It Matter? Dimitris Mavridis, PhD American Journal.

Volume 73, Issue 5, Pages (March 2008)

KDOQI US Commentary on the 2017 ACC/AHA Hypertension Guideline

Number of patients who would have benefitted from addition of ACE inhibitor (ACEi), beta blockers (BB) or optimal therapy (one or both of ACEi and BB)

Immunosuppression significantly reduced all-cause mortality or risk of ESRD (A) and significantly increased complete or partial remission (B) at the end.

(A) Distribution of CsA nephrotoxicity lesions according to antihypertensive treatment and CsA C2 levels. (A) Distribution of CsA nephrotoxicity lesions.

Unadjusted odds ratio of death at 6 mo for medications (β blockers [BBL], angiotensin-converting enzyme inhibitors [ACEI]/angiotensin receptor blockers.

Recommendations for the treatment of confirmed hypertension in people with diabetes. *An ACE inhibitor (ACEi) or angiotensin receptor blocker (ARB) is.

Combination angiotensin-converting enzyme inhibitor (ACEI)/angiotensin II receptor blocker (ARB) reduced risk for renal end point versus ACEI or ARB. Effect.

Proteinuria and hypertension with tyrosine kinase inhibitors

Percentage of patients found with a kidney function too low for recommended use of the drug using estimated glomerular filtration rate compared with creatinine.

Pathway to initial antihypertensive therapy in patients with diabetes

Recommendations for the treatment of confirmed hypertension in people with diabetes. *An ACE inhibitor (ACEi) or ARB is suggested to treat hypertension.

Kernel density plots of propensity score distributions in the included and excluded populations. Kernel density plots of propensity score distributions.

Fig. 3: Possible algorithm for controlling blood pressure in diabetic patients with microalbuminuria. [This algorithm is based on the opinions and practice.

Kaplan-Meier curve of the primary outcome in patients prescribed ACE inhibitor (ACEI) and angiotensin receptor blocker (ARB). Kaplan-Meier curve of the.

Presentation transcript:

An updated general approach for achieving BP goals in people with diabetes. An updated general approach for achieving BP goals in people with diabetes. This integrated approach summarizes the National Kidney Foundation consensus report and American Society of Hypertension guidelines (49,50). ACEI, ACE inhibitor; ARB, angiotensin receptor blocker; CCB, calcium channel blocker; K, potassium.*Diuretics such as chlorthalidone and indapamide. **Risk factors for hyperkalemia; note hyperkalemia is defined as serum potassium >5.5 mEq/L. Vikram Patney et al. Diabetes Spectr 2015;28:175-180 ©2015 by American Diabetes Association